10x Genomics, Inc. TXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.47M+60.8% | -$16.25M+66.9% | -$27.47M+23.2% | $34.54M+191% | -$34.36M+42.7% | ||
| $9.96M+24.1% | $10.07M+15.0% | $10.3M+14.9% | $7.82M-12.9% | $8.02M-12.7% | ||
| $22.64M-27.1% | $25.22M-22.5% | $25.26M-24.8% | $27.56M-28.4% | $31.08M-14.0% | ||
| $26.12M-24.0% | $40.78M— | $43.21M+99.7% | $17.71M— | $34.35M+318% | ||
| $1.6M-15.6% | $1.78M-34.6% | $687K-82.3% | $1.58M-45.2% | $1.89M-34.9% | ||
| -$1.31M+30.7% | -$1.81M+96.5% | -$8.8M-143% | -$939K-108% | -$1.89M-118% | ||
| -$8.42M-2,095% | $2.24M-50.4% | $617K+296% | $3.52M-23.5% | $422K-74.2% | ||
| $16.32M-50.5% | $41.26M+176% | $35M+90.9% | $20.65M-14.1% | $32.99M+1,042% | ||
| $24.52M-24.4% | $39M+512% | $42.53M+140% | $16.13M— | $32.46M+274% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does 10x Genomics, Inc. generate?
- 10x Genomics, Inc. (TXG) generated $127.8M in operating cash flow over the trailing twelve months.
- What is 10x Genomics, Inc.'s free cash flow?
- After $5.6M of capital expenditures, 10x Genomics, Inc.'s free cash flow was $122.2M over the trailing twelve months, up 452.6% year over year.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
